V025-1305 Screening compound: N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide

V025-1305 Screening compound: N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide
V025-1305 Screening compound: N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-1305
N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-1305

Molecular Formula

C23H30N6O (C23 H30 N6 O)

Compound Name

N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide

IUPAC name

N-[4-({6-ethyl-1-phenyl-1H-pyrazolo[34-d]pyrimidin-4-yl}amino)cyclohexyl]-2-methylpropanamide

SMILES

CCc1nc(n(-c2ccccc2)nc2)c2c(NC(CC2)CCC2NC(C(C)C)=O)n1

InChI

InChI=1S/C23H30N6O/c1-4-20-27-21(25-16-10-12-17(13-11-16)26-23(30)15(2)3)19-14-24-29(22(19)28-20)18-8-6-5-7-9-18/h5-9,14-17H,4,10-13H2,1-3H3,(H,26,30)(H,25,27,28)

InChI Key

OWRSGRIVKADHFU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14256181

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

406.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.260

Distribution Coefficient, logD

4.249

Water Solubility, LogSw

-3.96

Polar Surface Area

69.045

Acid Dissociation Constant (pKa)

15.43

Base Dissociation Constant (pKb)

5.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.80

V025-1305 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V025-1305 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-1305?
Check Price and Availability of V025-1305, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-1305 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-1305
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-1305
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-1305 available by request